Not all medications are alike, particularly when it comes to drugs for the treatment of ADHD. The FDA weighed in on the generic for Concerta back in 2014,1 and now a case series has shown that the generic methylphenidate extended release (ER) formulation that incorporates osmotic controlled-release oral-delivery system (OROS) technology may provide better, longer control of inattention than non-OROS formulations.